Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

From 2010 to 2020, breast cancer deaths among women ages 20–49 declined significantly across all breast cancer subtypes and ...

TNX-1700 is in preclinical development for gastric and colorectal cancers ...

The session follows the American Association for Cancer Research's prior call to action against executive orders that would ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

We are navigating political interference, institutional instability, and growing uncertainty across the cancer research ...

The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain ...